Combination therapy of pregabalin and gabapentin
Pro Research Analysisby 
Searched over 200M research papers
Combination Therapy of Pregabalin and Gabapentin: Efficacy and Clinical Use
Efficacy in Neuropathic Pain and Postherpetic Neuralgia
Combining pregabalin and gabapentin has been explored for patients with postherpetic neuralgia (PHN) who do not achieve adequate pain relief with monotherapy. In a small retrospective study, patients experienced a significant reduction in pain scores after switching to combination therapy, suggesting that this approach may be a viable option for refractory cases. However, the study also notes that this combination is not currently recommended by treatment guidelines and that larger, randomized controlled trials are needed to confirm these findings .
When comparing the two drugs individually, meta-analyses show that pregabalin tends to provide better pain relief and improvement in sleep for PHN and spinal cord injury-related neuropathic pain, while gabapentin is associated with fewer adverse effects and a better safety profile 67. Both drugs are effective for neuropathic pain, but the choice between them should consider patient-specific factors and potential side effects 67.
Safety and Adverse Effects of Combination Therapy
The combination of pregabalin and gabapentin can increase the risk of adverse effects such as drowsiness, dizziness, fatigue, and ataxia. Case reports highlight that these side effects may resolve when one of the drugs is discontinued, emphasizing the importance of careful prescribing and monitoring for therapeutic duplication . Both drugs, when used individually, are generally well-tolerated, but combining them may amplify side effects without clear evidence of added benefit .
Use in Other Conditions: Pruritus and Postoperative Pain
Pregabalin and gabapentin have also shown effectiveness in reducing pruritus and postoperative pain, such as after refractive eye surgery. Meta-analyses indicate that both drugs significantly reduce symptoms compared to placebo, with pregabalin often showing a slightly greater effect. Importantly, the incidence of adverse events does not significantly increase with either drug when used alone 458. However, these studies do not specifically address the safety or efficacy of using both drugs together for these indications.
Risks of Polydrug Use and Special Populations
There are significant risks when gabapentin or pregabalin are combined with other central nervous system depressants, such as opioids. Studies have shown that this combination can increase the risk of respiratory depression and overdose, particularly in populations with substance use disorders . This highlights the need for caution and close monitoring when considering combination therapy, especially in vulnerable groups.
Combination with Other Analgesics
While direct combination of pregabalin and gabapentin is not widely supported, both drugs can interact synergistically with other analgesics like naproxen to enhance pain relief in animal models. This suggests that combination strategies with different classes of drugs may offer therapeutic advantages for persistent pain, but more research is needed to confirm these findings in humans .
Conclusion
Combining pregabalin and gabapentin may offer additional pain relief for some patients with refractory neuropathic pain, but this approach is not currently recommended by guidelines due to limited evidence and increased risk of adverse effects 12. Both drugs are effective and generally safe when used individually for neuropathic pain, pruritus, and postoperative pain, with pregabalin often providing greater efficacy and gabapentin offering a better safety profile 4567+1 MORE. Clinicians should carefully weigh the potential benefits and risks, avoid therapeutic duplication, and monitor for side effects, especially in patients with complex medication regimens or substance use disorders 210. More robust clinical trials are needed to clarify the role of combination therapy in practice.
Sources and full results
Most relevant research papers on this topic